Clinical Trial Update: Evaluating Liraglutide in Alzheimer's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating liraglutide for Alzheimer's disease is ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• liraglutide (liraglutide)

Snippet

Sponsor: Imperial College London | Conditions: Alzheimer's Disease | Phase 2 | Status: UNKNOWN